NEJM Group

This Twitter account is no longer active. For up-to-date information and articles from NEJM Group, follow @NEJM, @NEJMCatalyst, @JWatch, @Physns1stWatch, @NEJMres360, @nejmkplus, and @NEJMLibHub.

An FDA advisory committee voted on Thursday that the potential benefits of the Pfizer and BioNTech #COVID19 #vaccine outweigh its risks for people ages 16 years and up.

Celebrating our anniversary today! 🎉 One year ago, we launched NEJM Catalyst Innovations in Care Delivery. NEJM Catalyst itself turns five. Please enjoy some virtual cake, on us. 🍰

#ASH2020: A preliminary study shows that patients on chronic anticoagulant or antiplatelet drugs for other conditions do not fare better than other patients after receiving a diagnosis of #COVID19. Dr. Gwendolyn Ho chats with @NEJMGroup’s Joe Elia. jwat.ch/39R6Jb2

.@PaulSaxMD offers some tips for getting through the next few months safely -- and with some joy -- while we await widespread vaccination against #COVID19. jwat.ch/2VHpAgu

Pfizer and BioNTech's mRNA #vaccine against #SARSCoV2 seems to start working soon after the first dose. Meanwhile, the AstraZeneca vaccine showed 62% efficacy among people who received two full doses and 90% efficacy among those who received a half-dose followed by a full dose.

A preliminary study in California shows that patients on chronic anticoagulant or antiplatelet drugs for other conditions don't fare any better than other patients after receiving a diagnosis of #COVID19. Dr. Gwendolyn Ho chats with Joe Elia. jwat.ch/39R6Jb2 #ASH20

#ASH20 news from @NEJMGroup: Joe Elia interviews Dr. Bhavana Bhatnagar. She reports that African-American patients aged <60 with acute myeloid leukemia have lower 3-year survival compared with whites: 32% vs. 41%. jwat.ch/39P1BUL @BhavanaBhatnag4

#ASH2020 news from @NEJMGroup: Dr. Terry Gernsheimer discusses her team's research on the prophylactic use of tranexamic acid in patients undergoing treatment for hematologic malignancies jwat.ch/2LdbCRB

Inhaled corticosteroids can be used as needed to manage symptoms in patients aged 12 years and up with mild or moderate persistent #asthma, according to updated asthma guidelines from the National Asthma Education and Prevention Program.

Pooled #SARSCoV2 Surveillance Testing at a U.S. University: Benefits and Costs jwat.ch/3lvdDF1 #COVID19

The CDC has shortened the minimum amount of time people have to quarantine after a potential #COVID19 exposure from 14 days to as few as 7 days as long as the person is symptom free and tests negative.

Anticholinergic medications increase the risk for #MildCognitiveImpairment in cognitively normal adults: jwat.ch/37uhzBf

What is your organization doing to advance the transformation of health care? Visit our author center and let us know: catalyst.nejm.org/author-center #HealthCareDelivery #HCLDR #HealthCareInnovation

The CDC's advisory committee voted 13-1 on Tuesday in favor of prioritizing both healthcare workers and residents of long-term-care facilities for vaccination against #SARSCoV2 during the initial phase of vaccination. #vaccine #COVID19

From the Insights on Residency Training blog: @VivekSantMD, who has seen residents collectively judge each new class of interns since his own intern year, muses about the culture shift he sees happening in residency training today. jwat.ch/3fySo46

.@PaulSaxMD summarizes great ID questions from a recent online course he co-teaches at Harvard Medical School. jwat.ch/33uMaNP

In response to its outstanding reception, NEJM Catalyst Innovations in Care Delivery is doubling its frequency to 12 issues per year. Learn about the journal and visit our author center: catalyst.nejm.org/about/journal #HealthCareDelivery #HCLDR #HealthCareInnovation

.@PaulSaxMD offers his list of ID-related things to be thankful for (even in 2020) in his HIV and ID Observations blog. jwat.ch/3ftb8BX

The FDA has issued emergency use authorizations for two new #COVID19 treatments, including the antibody cocktail President Donald Trump received early in his illness.